Supporting neurological decision making with AI

Theia AI software extracts actionable insights from medical images and patient data to add clinical value and support treatment decisions.

Learn More

2.8 MILLION people are affected by Multiple Sclerosis (MS) globally¹

MS presents as a wide range of symptoms that can significantly impact a person's quality of life. These can range from more common symptoms such as fatigue, blurred vision and numbness, to less common symptoms such as problems with hearing, speech and swallowing².

¹Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition,.
Walton, C. et. al. (2020)

²National Multiple Sclerosis Society, Symptoms & Diagnosis.

MS costs the US $85.4 billion annually

These costs are are made up of $63bn on direct medical costs including medication, $21bn in societal costs such as missed work, and $1.1bn in caregiving and home modifications³.

³National Multiple Sclerosis Society, Cost of Multiple Sclerosis..

Multiple Sclerosis is a relapsing disease that requires monitoring

80% of patients begin with relapsing-remitting MS where they experience periods of worsening symptoms (relapse) followed by recovery periods (remitting)⁴.

After 25 years, roughly 80% develop secondary-progressive MS where symptoms steadily worsen⁵.

⁴Multiple Sclerosis, Natural Library of Medicine.
Noseworthy, J. et al. (2000)

⁵The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability.
Scalfari, A. (2010)

MRIs play a vital role in diagnosis and the choice of therapy

MS is diagnosed through a combination of clinical evaluation and brain imaging in accordance with the McDonald Criteria⁶.

To signal changes in the disease and manage treatment to slow the progression of the disease, patients are recommended regular monitoring with brain MRI scans every 12-32 months.

⁶Diagnosis of multiple sclerosis: 2017 revisions of the McDonald Criteria.
Thompson, A. et al. (2017)